01.07.2009 | Clinical Investigation
One-year results of intravitreal ranibizumab for neovascular age-related macular degeneration and clinical responses of various subgroups
Erschienen in: Japanese Journal of Ophthalmology | Ausgabe 4/2009
Einloggen, um Zugang zu erhalten